Skip to content

cesarean incision in Primiparous patients

Evaluation of the effect of silica Q10 tablet on cesarean incision in Primiparous patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014111719982N1
Enrollment
260
Registered
2015-03-13
Start date
2013-12-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wound cesarean. Maternal care due to uterine scar from previous surgery

Interventions

Intervention 1: Intervention group: silica Q10 pills for 7 days after delivery. Intervention 2: Control group: placebo daily for 7 days after delivery.
Treatment - Drugs
Intervention group: silica Q10 pills for 7 days after delivery
Control group: placebo daily for 7 days after delivery

Sponsors

Arak University Of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients prom 18 hours or less; less than 24 hours during the hospitalization; surgery time is less than 60 minutes; more than 36 weeks gestational age; body mass index less than 30. Exclusion criteria: the pre-operative fever; urinary symptoms, lack of patient follow-up 10 days after cesarean; underlying diseases such as diabetes and hypertension; oral or intravenous antibiotics before surgery for other causes; Cesarean section because of lack of progress in the second stage of labor and the use of corticosteroids (Betamethasone or Dexamethasone; except for fetal lung maturation)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Healing. Timepoint: 7 days after delivery. Method of measurement: Observation.

Secondary

MeasureTime frame
Infection. Timepoint: 7 days after delivery. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ashraf Zamani

Arak University of medical science

ashrafzamani@rocketmail.com+98 86 3465 5314

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026